MAKO Surgical Corp. (MAKO) Neutralizes the Competition: Buy?

By collaborating with Stanmore, MAKO could then effectively offset Blue Belt’s edge, thereby making its RIO platform that much more attractive to prospective customers.

Foolish final thoughts
As a MAKO investor, I’m relieved neither of these challenges turned out to be long, drawn-out ordeals. To the contrary, I think the fact both complaints were so quickly and succinctly resolved can be seen as a significant vote of confidence supporting the viability of MAKO’s business.

With all things considered, I’m convinced that patient long-term investors who buy shares of MAKO Surgical Corp. (NASDAQ:MAKO) today should be more than pleased with the results. With shares of MAKO trading up nearly 6% as of this writing, it would seem like the market agrees.

The article MAKO Neutralizes the Competition: Is the Stock a Buy? originally appeared on Fool.com.

Fool contributor Steve Symington owns shares of MAKO Surgical . The Motley Fool recommends MAKO Surgical.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.